Article Details
Retrieved on: 2021-06-30 11:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Kiromic BioPharma has granted the underwriters a 45-day option to purchase up to an additional 1.2 million shares to cover over-allotments. All of the ...
Article found on: www.marketwatch.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here